Stifel Financial Corp Checkpoint Therapeutics, Inc. Transaction History

Stifel Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$2.15 - $3.36 $22,777 - $35,595	-10,594 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.75 - $5.0 $2,142 - $3,895	-779 Reduced 6.85%	10,594 $33,000
Q1 2019 May 14, 2019	BUY	$2.01 - $4.01 $235 - $469	117 Added 1.04%	11,373 $33,000
Q4 2018 Feb 13, 2019	SELL	$1.54 - $3.35 $9,857 - $21,443	-6,401 Reduced 36.25%	11,256 $22,000
Q3 2018 Nov 13, 2018	BUY	$2.46 - $4.72 $43,436 - $83,341	17,657 New	17,657 $64,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $304M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.